Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) breached their fiduciary duties to Acadia Healthcare and its shareholders.
Scott+Scott is investigating whether members of the Acadia Healthcare board of directors or senior management failed to manage Acadia Healthcare in an acceptable manner, in breach of their fiduciary duties to Acadia Healthcare, and whether Acadia Healthcare and its shareholders have suffered damages as a result.On September 1, 2024, the New York Times published an investigative article detailing unlawful and unethical practices at Acadia Healthcare, including improperly detaining psychiatric patients in Acadia Healthcare facilities against their will. A second article was published on December 7, 2024, detailing fraud and falsification of records at Acadia Healthcare methadone clinics. On April 22, 2025, the New York Times published a third article regarding Acadia Healthcare, alleging suicides and rapes at one of Acadia Healthcare’s facilities outside Chicago due in part to insufficient staffing.Acadia Healthcare has acknowledged several governmental investigations on the above, including by the Criminal Division of the U.S. Department of Justice and the Securities and Exchange Commission, as well as Congressional inquiries. In addition, a securities class action lawsuit has been filed against Acadia Healthcare and its top management.
If you own shares of Acadia Healthcare, you may have legal claims against Acadia Healthcare’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew:
Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
(844) 818-6982